grant PAS-25-205

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

The SHINE program provides funding for innovative and high-quality research in nonmalignant hematology. It supports investigator-initiated R01 grant applications relevant to the missions of NIDDK, NIA, and NHLBI. The program focuses on advancing basic and early translational research in nonmalignant hematology, with priority topics that are updated yearly.

The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), a…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases

Dates

Opportunity Released: November 6, 2024
Open for Submission: November 6, 2024
Submission Deadline: January 6, 2028
Application Window Closes: January 6, 2028

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.